Innovative Technology Acquisition Corporation Completes Acquisition of BioSource Therapeutics, Inc.Business Editors/Health & Medical Writers
NEW YORK--(BUSINESS WIRE)--Nov. 6, 2002
BioSource Therapeutics is a developer of nutritional supplements Nutritional Supplements Definition
Nutritional supplements include vitamins, minerals, herbs, meal supplements, sports nutrition products, natural food supplements, and other related products used to boost the nutritional content of the diet.
that address chronic nutritional issues in patients resulting from
diseases such as HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome , Cancer and Hepatitis
Innovative Technology Acquisition Corporation (OTCBB OTCBB
See OTC Bulletin Board (OTCBB). :ITAQ) has acquired 100 percent of BioSource Therapeutics, Inc. (BST (convention) BST - British Summer Time. The name for daylight-saving time in the UK GMT time zone. ), a life science biotechnology corporation dedicated to the research and development of innovative dietary supplements that address the effects of epidemic viral infections. BST is currently developing a product that addresses the needs of people with catabolic Catabolic
A metabolic process in which energy is released through the conversion of complex molecules into simpler ones.
Mentioned in: Anabolic Steroid Use
see catabolism. caexiea, commonly referred to as "wasting syndrome Wasting syndrome
A progressive loss of weight and muscle tissue caused by the AIDS virus.
Mentioned in: AIDS
wasting syndrome " related to diseases such as HIV/AIDS, Hepatitis and Cancer.
"The acquisition of BioSource Therapeutics is a positive step forward for the company," said Randy Lebow, President of Innovative Technology Acquisition Corporation. "The dietary supplement that BST is currently developing is intended to address the immunological considerations of progressive weight loss in chronic morbid disease management. The product is intended to be eligible for insurance reimbursement, and the Company will immediately seek approvals in key states, targeting Medicaid populations. The Company's strategic plan is on target, and we anticipate having product available and generating sales and revenues in the first quarter of 2003."
According to the AIDS Nutrition Services Alliance "Proper nutrition proper nutrition,
n in Tibetan medicine, a therapeutic concept that begins with a digestive formulation because it is believed that a medical condition is primarily the result of a nutritional dysfunction or disturbance in the process of delivering nutrients. is a powerful tool for the successful management of HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. disease. Medical research confirms that weight loss - especially muscle tissue wasting - often leads to malnutrition and is a fatal manifestation of AIDS. Malnutrition has also been identified as a distinct cofactor cofactor
An atom, organic molecule, or molecular group that is necessary for the catalytic activity (see catalysis) of many enzymes. A cofactor may be tightly bound to the protein portion of an enzyme and thus be an integral part of its functional structure, or it may contributing to HIV disease progression. In cases where new treatments prolong the lives of people living with HIV/AIDS, long-term survivors will benefit substantially from proper nutrition."
BioSource Therapeutics, Inc. is a research and development company that brings the latest cutting-edge biotechnologies together to create nutraceutical products that provide nutritional supplement solutions for people with debilitating de·bil·i·tat·ing
Causing a loss of strength or energy.
Weakening, or reducing the strength of.
Mentioned in: Stress Reduction , chronic diseases. BST is pioneering in the emerging scientific field of nutritional supplements to support traditional medical treatments and therapies.
Innovative Technology Acquisition Corporation identifies and acquires new nutraceutical products and companies with promising growth potential.
Statements made in this news release, other than statements of historical fact, are forward-looking statements and are subject to a number of uncertainties that could cause actual results to differ materially from the statements made, including risks associated with the success of product development programs, the regulatory approval process, competitive products, and future capital requirements. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results such as, but not limited to: the ability of the Company to raise necessary capital; to attract and retain effective management; the lack of regulatory approvals or the failure of third-party contractors to perform their contractual obligations. Prospective investors are also referred to the other risks identified from time to time in the Company's reports and registration statements filed with the Securities and Exchange Commission